vs
Local Bounti Corporation（LOCL）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Local Bounti Corporation的季度营收约是Protalix BioTherapeutics, Inc.的1.4倍（$12.5M vs $9.1M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -69.8%，领先9.5%），Local Bounti Corporation同比增速更快（23.7% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-3.6M），过去两年Local Bounti Corporation的营收复合增速更高（21.9% vs -6.7%）
Local Bounti是总部位于美国的可持续室内农业企业，采用水培和垂直农业技术种植无农药绿叶蔬菜、香草等生鲜农产品，主要服务北美零售连锁超市及餐饮客户，主打低环境影响、短供应链的全年稳定供货。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
LOCL vs PLX — 直观对比
营收规模更大
LOCL
是对方的1.4倍
$9.1M
营收增速更快
LOCL
高出73.6%
-49.9%
净利率更高
PLX
高出9.5%
-69.8%
自由现金流更多
PLX
多$5.3M
$-3.6M
两年增速更快
LOCL
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.5M | $9.1M |
| 净利润 | $-8.7M | $-5.5M |
| 毛利率 | 12.2% | 49.4% |
| 营业利润率 | -106.1% | -51.1% |
| 净利率 | -69.8% | -60.3% |
| 营收同比 | 23.7% | -49.9% |
| 净利润同比 | 76.0% | -184.8% |
| 每股收益（稀释后） | $1.52 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LOCLPLX
| Q4 25 | $12.5M | $9.1M | ||
| Q3 25 | $12.2M | $17.9M | ||
| Q2 25 | $12.1M | $15.7M | ||
| Q1 25 | $11.6M | $10.1M | ||
| Q4 24 | $10.1M | $18.2M | ||
| Q3 24 | $10.2M | $18.0M | ||
| Q2 24 | $9.4M | $13.5M | ||
| Q1 24 | $8.4M | — |
净利润LOCLPLX
| Q4 25 | $-8.7M | $-5.5M | ||
| Q3 25 | $-26.4M | $2.4M | ||
| Q2 25 | $-21.6M | $164.0K | ||
| Q1 25 | $-37.7M | $-3.6M | ||
| Q4 24 | $-36.3M | $6.5M | ||
| Q3 24 | $-34.3M | $3.2M | ||
| Q2 24 | $-25.3M | $-2.2M | ||
| Q1 24 | $-24.1M | — |
毛利率LOCLPLX
| Q4 25 | 12.2% | 49.4% | ||
| Q3 25 | 11.5% | 53.4% | ||
| Q2 25 | 12.2% | 62.5% | ||
| Q1 25 | 12.6% | 19.1% | ||
| Q4 24 | 5.4% | 78.7% | ||
| Q3 24 | 13.8% | 53.4% | ||
| Q2 24 | 14.3% | 29.8% | ||
| Q1 24 | 9.4% | — |
营业利润率LOCLPLX
| Q4 25 | -106.1% | -51.1% | ||
| Q3 25 | -149.4% | 11.9% | ||
| Q2 25 | -127.7% | 7.5% | ||
| Q1 25 | -135.6% | -41.0% | ||
| Q4 24 | -166.6% | 39.6% | ||
| Q3 24 | -176.0% | 22.2% | ||
| Q2 24 | -146.8% | -18.0% | ||
| Q1 24 | -122.9% | — |
净利率LOCLPLX
| Q4 25 | -69.8% | -60.3% | ||
| Q3 25 | -216.6% | 13.2% | ||
| Q2 25 | -178.3% | 1.0% | ||
| Q1 25 | -324.6% | -35.8% | ||
| Q4 24 | -360.1% | 35.6% | ||
| Q3 24 | -335.2% | 18.0% | ||
| Q2 24 | -267.6% | -16.4% | ||
| Q1 24 | -286.9% | — |
每股收益（稀释后）LOCLPLX
| Q4 25 | $1.52 | $-0.06 | ||
| Q3 25 | $-1.18 | $0.03 | ||
| Q2 25 | $-1.63 | $0.00 | ||
| Q1 25 | $-4.32 | $-0.05 | ||
| Q4 24 | $-4.24 | $0.10 | ||
| Q3 24 | $-4.01 | $0.03 | ||
| Q2 24 | $-3.00 | $-0.03 | ||
| Q1 24 | $-2.89 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.2M | $14.7M |
| 总债务越低越好 | $483.1M | — |
| 股东权益账面价值 | $-166.2M | $48.2M |
| 总资产 | $410.5M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LOCLPLX
| Q4 25 | $4.2M | $14.7M | ||
| Q3 25 | $6.2M | $13.6M | ||
| Q2 25 | $5.3M | $17.9M | ||
| Q1 25 | $18.0M | $19.5M | ||
| Q4 24 | $937.0K | $19.8M | ||
| Q3 24 | $317.0K | $27.4M | ||
| Q2 24 | $9.7M | $23.4M | ||
| Q1 24 | $8.2M | — |
总债务LOCLPLX
| Q4 25 | $483.1M | — | ||
| Q3 25 | $484.9M | — | ||
| Q2 25 | $478.3M | — | ||
| Q1 25 | $480.0M | — | ||
| Q4 24 | $436.8M | — | ||
| Q3 24 | $398.4M | — | ||
| Q2 24 | $374.0M | — | ||
| Q1 24 | $329.8M | — |
股东权益LOCLPLX
| Q4 25 | $-166.2M | $48.2M | ||
| Q3 25 | $-158.1M | $52.9M | ||
| Q2 25 | $-132.7M | $49.9M | ||
| Q1 25 | $-134.5M | $45.2M | ||
| Q4 24 | $-100.5M | $43.2M | ||
| Q3 24 | $-65.6M | $32.4M | ||
| Q2 24 | $-32.8M | $28.6M | ||
| Q1 24 | $-9.4M | — |
总资产LOCLPLX
| Q4 25 | $410.5M | $82.3M | ||
| Q3 25 | $417.8M | $82.3M | ||
| Q2 25 | $426.8M | $78.5M | ||
| Q1 25 | $447.2M | $73.9M | ||
| Q4 24 | $428.0M | $73.4M | ||
| Q3 24 | $430.8M | $61.6M | ||
| Q2 24 | $438.1M | $91.5M | ||
| Q1 24 | $413.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.1M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | $1.6M |
| 自由现金流率自由现金流/营收 | -29.1% | 17.8% |
| 资本支出强度资本支出/营收 | 3.9% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-42.9M | $-13.6M |
8季度趋势，按日历期对齐
经营现金流LOCLPLX
| Q4 25 | $-3.1M | $2.0M | ||
| Q3 25 | $-8.9M | $-3.7M | ||
| Q2 25 | $-8.7M | $-5.2M | ||
| Q1 25 | $-9.6M | $-5.1M | ||
| Q4 24 | $1.2M | $4.0M | ||
| Q3 24 | $-17.2M | $4.1M | ||
| Q2 24 | $-4.0M | $-3.6M | ||
| Q1 24 | $-7.1M | — |
自由现金流LOCLPLX
| Q4 25 | $-3.6M | $1.6M | ||
| Q3 25 | $-10.1M | $-4.2M | ||
| Q2 25 | $-14.6M | $-5.7M | ||
| Q1 25 | $-14.5M | $-5.4M | ||
| Q4 24 | $-8.6M | $3.6M | ||
| Q3 24 | $-30.0M | $4.0M | ||
| Q2 24 | $-28.8M | $-3.8M | ||
| Q1 24 | $-42.1M | — |
自由现金流率LOCLPLX
| Q4 25 | -29.1% | 17.8% | ||
| Q3 25 | -82.8% | -23.7% | ||
| Q2 25 | -121.0% | -36.2% | ||
| Q1 25 | -125.1% | -53.0% | ||
| Q4 24 | -85.3% | 19.6% | ||
| Q3 24 | -293.1% | 22.4% | ||
| Q2 24 | -305.4% | -28.1% | ||
| Q1 24 | -501.8% | — |
资本支出强度LOCLPLX
| Q4 25 | 3.9% | 4.4% | ||
| Q3 25 | 9.7% | 2.8% | ||
| Q2 25 | 48.9% | 2.8% | ||
| Q1 25 | 42.8% | 3.0% | ||
| Q4 24 | 97.6% | 2.3% | ||
| Q3 24 | 125.0% | 0.5% | ||
| Q2 24 | 263.0% | 1.3% | ||
| Q1 24 | 417.3% | — |
现金转化率LOCLPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LOCL
暂无分部数据
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
